Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Sound Waves Could Provide New Tool To Fight Cancer

Sound waves may become the next effective tool to help doctors diagnose cancer and develop more personalized diagnostics and treatments. A new study conducted by researchers from Duke University, MIT and Singapore's Nanyang Technological University shows that sound waves are capable of rapidly and...

Tim McGraw Sends Video Message To Cancer Patient

Kathy Wolf was hospitalized at Duke in late June due to a complication from end-stage ovarian cancer. The Youngsville resident kept asking whether she’d be able to leave the hospital in time to go see one of her favorite singers, country music star Tim McGraw, at his concert in Raleigh on Friday,...

Join DCI In Making Strides Against Breast Cancer

Duke Cancer Institute, for a fourth year, is partnering with the American Cancer Society (ACS) to serve as local presenting sponsor for its annual Making Strides Against Breast Cancer walk, to be held Saturday, Oct. 13, at Midtown Park at North Hills, Raleigh, North Carolina. Last year’s event...

Sellers Wins LLS Woman Of The Year Title

Catherine Sellers, MSN, RN, AGPCNP-BC,OCN, Duke Cancer Center Raleigh, was recently named the The Leukemia and Lymphoma Society’s (LLS) 2018 Woman of the Year. Having raised $167,098 over a 10-week period (March 27 through June 9), Seller's cinched the local chapter's Woman of the Year title. "...

Poliovirus Therapy for Recurrent Glioblastoma Has Three-Year Survival Rate of 21 Percent

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival rate of 21 percent in a phase 1 clinical trial. Comparatively, just four percent of patients at Duke with...

Can Your Treatment Regimen Affect Your Cardiovascular Health?

Nestled in the woods of Duke Forest, you will find the Center for Living Campus at Duke University. It’s an early spring morning as Harry “Randy” Chambers arrives for his weekly exercise appointment. Once inside the building’s walls, Chambers begins to warms up with a brisk walk around the track. “...

Barbour Named To HOPA Board of Directors

Sally Yowell Barbour, PharmD, BCOP, CPP, FHOPA, director of Oncology Pharmacy Programs and clinical oncology pharmacist at Duke Cancer Institute, was recently appointed to the Hematology/Oncology Pharmacy Association ( HOPA ) Board of Directors where she serves at secretary. “I am honored and...

Strike Out For Sarcoma

Step out on Sunday, Sept. 9, for the 9th Annual Strike Out For Sarcoma 5K and Family Run . The event, hosted by the Duke Multidisciplinary Sarcoma Program, takes place WakeMed Soccer Field in Cary, North Carolina. According to the American Cancer Society a sarcoma is a type of cancer that develops...

Hundreds Attend Supportive Care & Survivorship Days

Hundreds of patients, caregivers, survivors and loved ones attended Duke Cancer Institute’s annual Supportive Care and Survivorship Day held in two locations on two different days — at Duke Raleigh Cancer Center on June 5 and at Duke Cancer Center in Durham on June 6. More than 300 total visitors (...

Clarke To Lead Team DCI At 2018 LUNGe Forward 5K

The Lung Cancer Inititative of North Carolina will host its 12th annual LUNGe Forward 5K on Sunday, Sept. 23, at 12:30 p.m. at Midtown Park at North Hills in Raleigh, North Carolina. Team Duke Cancer Institute will be led this year by Jeffrey Clarke , MD, a medical oncologist specializing in...

Newly Identified Genetic Markers Classify Previously Undetermined GBM Tumors

Most glioblastoma tumors are marked by one or two broad mutation patterns, but about 20 percent of the lethal brain tumors have biomarkers that cannot be identified. Now scientists at Duke Cancer Institute have identified mutations for the vast majority of the remaining 20 percent of...

Patient’s Advice: Nourish The Soul     

Nadine Tolman takes a sip of water from a plastic cup that her husband, Fay, has just brought her from the refreshment station. “Remember, you need to stay hydrated,” he says softly, laying his hand on her shoulder, “and don’t forget to eat your lunch.” The gentle gesture from her husband disrupts...

Pages